news
Sandoz to give insight on European biosimilar trends at 7th Annual Congress
21 July 2016 | By SMi Group
Sandoz added onto Biosimilars Europe speaker line-up alongside ABPI, IMS Health and Boehringer Ingelheim...
List view / Grid view
Boehringer Ingelheim
news
A new, highly accurate way of proving how new drugs work
6 July 2016 | By Cold Spring Harbor Laboratory (CSHL)
Researchers have identified a new drug target in AML, created a candidate drug that hits the target and developed a new way of proving how the drug works...
news
Boehringer Ingelheim and Inventiva enter IPF collaboration
31 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim and Inventiva have entered a research and drug discovery collaboration with the aim of discovering new IPF treatments...
news
Project to apply crowdsourcing for new treatment approaches for psychiatric diseases
23 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim and BioMed X have established a research team that will conduct research to identify new treatment approaches for psychiatric diseases...
news
LDC and Boehringer Ingelheim join forces to discover schizophrenia treatment
11 May 2016 | By Victoria White, Digital Content Producer
Boehringer Ingelheim will have the option of exclusive rights to a new compound for the treatment of schizophrenia to be discovered and developed at the LDC...
news
VTU Technology and Boehringer Ingelheim extend collaboration
27 April 2016 | By Victoria White, Digital Content Producer
After successful completion of a first development programme, Boehringer Ingelheim is now widening the scope of its collaboration with VTU Technology...
news
Amal Therapeutics completes EUR 2.75 million Series A financing round
30 March 2016 | By Victoria White
Amal Therapeutics will use the funds to progress the preclinical development of ATP124 and to further develop its KISIMA technology platform...
article
Pushing the limits of protein expression with miRNAs
Biopharmaceuticals are highly complex protein drugs such as antibodies, cytokines and peptide hormones, which are used for a variety of indication areas, including immunology, neurology, metabolic diseases and cancer. These modern protein drugs may hinder progression of a disease, ease symptoms or assure – in the case of chronic diseases…
news
Winners of innovative cardiovascular research grant programme announced
11 February 2016 | By Victoria White
The European Society of Cardiology awarded the grants to research projects that will address areas of unmet medical need in thromboembolic disease...
news
Boehringer and Arena to advance research in psychiatric diseases
13 January 2016 | By Victoria White
Boehringer Ingelheim and Arena Pharmaceuticals have signed an exclusive agreement to conduct joint research to identify drug candidates for psychiatric diseases...
news
Boehringer Ingelheim and MD Anderson in pancreatic cancer collaboration
2 December 2015 | By Victoria White
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Centre are to focus on developing new medicines for pancreatic ductal adenocarcinoma...
news
Boehringer Ingelheim pledges EUR 11 billion to R&D
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
news
Boehringer Ingelheim announces IBD research collaborations
10 November 2015 | By Victoria White
The collaborations aim to identify and validate potential new therapeutic targets as well as identify biomarkers...
news
Collaboration to investigate acute myeloid leukaemia therapeutic approaches
12 October 2015 | By Victoria White
Boehringer Ingelheim and Philogen have agreed on an exploratory trial investigating novel immunotherapy concepts for relapsed acute myeloid leukaemia patients...
news
Global and USA Biosimilar Market: Latest updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
7 October 2015 | By SMi Group
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...